Eupraxia Pharmaceuticals Inc.
EPRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $108 | $94 | $77 | $53 |
| - Cash | $33 | $19 | $25 | $21 |
| + Debt | $0 | $10 | $12 | $10 |
| Enterprise Value | $75 | $85 | $64 | $42 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$36 | -$28 | -$18 | -$17 |
| % Margin | – | – | – | – |
| Net Income | -$37 | -$28 | -$18 | -$18 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.76 | -1.17 | -0.96 | -1.61 |
| % Growth | 35% | -21.9% | 40.4% | – |
| Operating Cash Flow | -$30 | -$21 | -$14 | -$12 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$30 | -$21 | -$15 | -$12 |